Access cutting-edge hcc treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Indianapolis location
Preparing your pre-screening questions…
Access hcc specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hcc treatment provided free
Check if you qualify for this hcc clinical trial in Indianapolis, IN
No-Cost Study Care
Local to Indianapolis
Convenient for IN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is a pilot, multi-center randomized controlled trial testing the HCC Liver-Link intervention, a culturally tailored, multi-level program designed to reduce racial disparities in hepatocellular carcinoma (HCC) care. The intervention combines: (1) patient education to improve HCC-related disease and treatment knowledge, (2) social needs and substance use screening with referral to social work and community resources, and (3) facilitated access to subspecialty cancer care through a multidisciplinary HCC tumor board. A total of 40 Black patients with Barcelona Clinic Liver Cancer (BCLC) stage 0, A, or downstaged B disease will be randomized to receive either the HCC Liver-Link intervention or usual care and followed for 6 months or until liver transplant waitlisting. Primary outcomes are time to receipt of curative therapies (liver transplantation or resection) and change in HCC-related knowledge. Findings will inform development of larger interventions to eliminate racial disparities in HCC outcomes.
Sponsor: Indiana University
Yes, this clinical trial (NCT06728293) has an active research site in Indianapolis, IN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hcc treatment options in Indianapolis, IN, this clinical trial (NCT06728293) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hcc specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hcc clinical trials near you to find additional studies recruiting in your area.
See all liver cancer clinical trials recruiting in Indianapolis — not just this study.
Browse Liver Cancer Trials in Indianapolis →